BCL2 and neoplasm: The expression of Bcl-2 is significantly higher in human glioblastoma and, in a PDGF-B–dependent mouse model of oligodendroglioma, Bcl-2 promoted tumor proliferation and progression to anaplastic disease (29, 30).